[1]
“Targeting Tumor Microenvironment Modulation for Improved Outcomes in Immunotherapy-Based Cancer Treatments”, PJOI, vol. 1, no. 1, pp. 4–12, Dec. 2024, doi: 10.70818/pjoi.2024.v01i01.028.